Sugi Predict

Sugi Predict / Targets / POF1B

POF1B

Protein POF1B · Q8WVV4 · POF1B on Sugi Atlas →

0 patent compounds predicted against POF1B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to POF1B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF) PHASE1/PHASE2UNKNOWN
It is a Real The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure PHASE1/PHASE2COMPLETED
A Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Premature Ovarian Insufficiency PHASE1/PHASE2ACTIVE_NOT_RECRUITING
A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Failure PHASE1COMPLETED
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer PHASE1RECRUITING
The Use of DHEA in Women With Premature Ovarian Failure EARLY_PHASE1WITHDRAWN
Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency nanUNKNOWN
X-Chromosome Inactivation Status and Premature Ovarian Failure nanCOMPLETED
Premature Ovarian Failure (Genetic and Physiopathologic Analysis) nanUNKNOWN
Ovarian Stem Cells From Women With Ovarian Insufficiency nanCOMPLETED
Prospective Genetic Study in Patients With Ovarian Insufficiency nanUNKNOWN
Investigation of Copy Number Variations and Genetic Variants in POI nanRECRUITING
Genetic Analysis of Familial Cases of Premature Ovarian Failure nanCOMPLETED
Cohort Study to Evaluate Ovarian Function nanUNKNOWN
Ovarian Reserve and Matrix Metalloproteinases nanCOMPLETED
Evaluation of Child Desire in Young Women With Premature Ovarian Failure nanUNKNOWN
Development a Predictive Nomogram for Primary Ovarian Insufficiency nanUNKNOWN
A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency nanRECRUITING
Precise Stratification of Genetic Risk of Ovarian Function Impairment nanUNKNOWN
Oxidative Stress Gene Polymorphism and Ovarian Reserve Functione nanUNKNOWN
Rejuvenation of Premature Ovarian Failure With Stem Cells nanCOMPLETED
Assessment of Ovarian Reserve in Patients With Fragile X Premutation nanRECRUITING
Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer nanACTIVE_NOT_RECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
The Bone Metabolism Characteristics of Premature Ovarian Insufficiency nanRECRUITING
Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements nanRECRUITING
PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer nanNOT_YET_RECRUITING
The Cycle Disturbances, OLigomenorrhea and Amenorrhea (COLA) Study & Biobank nanUNKNOWN
Sexuality and Sexual Quality of Life in Adult Patients With Turner Syndrome (TS) Compared With Patients With Primary Ovarian Insufficiency Different From TS nanUNKNOWN
Causes and Consequences of Primary Ovarian Insufficiency nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a POF1B binder may also engage these)

ProteinNameSimilarity
Q5RBB5 — 1.000 Q5RBB5 →
Q8K4L4 — 1.000 Q8K4L4 →
Q6NRK1 — 0.992 Q6NRK1 →
Q5SZL2 — 0.992 Q5SZL2 →
Q9CZX2 — 0.991 Q9CZX2 →
B8A5S6 — 0.990 B8A5S6 →
Q96ST8 — 0.990 Q96ST8 →
Q28GJ0 — 0.989 Q28GJ0 →
Q5BJF6 — 0.989 Q5BJF6 →
A7MD70 — 0.989 A7MD70 →
Q6TFL3 — 0.989 Q6TFL3 →
Q8R2H7 — 0.989 Q8R2H7 →
Q8VC66 — 0.988 Q8VC66 →
Q9H2G9 — 0.988 Q9H2G9 →
A0A1W2P884 — 0.988 A0A1W2P884 →
Q86SQ7 — 0.988 Q86SQ7 →
Q4R703 — 0.988 Q4R703 →
Q6ZU80 — 0.987 Q6ZU80 →
A4IIE8 — 0.987 A4IIE8 →
O60296 — 0.987 O60296 →
Q08DR9 — 0.987 Q08DR9 →
O94986 — 0.987 O94986 →
A0A1L8GXY6 — 0.987 A0A1L8GXY6 →
Q6DIS8 — 0.987 Q6DIS8 →
Q5ZMC9 — 0.987 Q5ZMC9 →
Q2MJV9 — 0.987 Q2MJV9 →
Q6NRW2 — 0.987 Q6NRW2 →
Q6P3P1 — 0.986 Q6P3P1 →
Q6P6L0 — 0.986 Q6P6L0 →
A0M8T5 — 0.986 A0M8T5 →